Pure Global
NCT04911088

Electromyographic Calibration Guided by Depth of Anesthesia

Does Calibration of Electromyography Guided by State Entropy Improve Measurement Precision
University Hospital Ulm·ClinicalTrials.govRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Neuromuscular Blockade
Study type
Observational
Sponsor & location
Primary sponsor
University Hospital Ulm
Location
Ulm, Germany
Timeline & enrollment
Phase
N/A
Start date
Jan 16, 2022
End date
Dec 01, 2022
Enrollment
60 participants
Primary outcome

Tolerance interval of TOF ratios

Summary

The goal of the CELESTE study is to evaluate whether calibration of EMG is needed for
 reliable interpretation of neuromuscular function and if so, to identify the minimal
 necessary depth of anesthesia.

ICD-10 classifications
Skeletal muscle relaxants [neuromuscular blocking agents]Poisoning: Skeletal muscle relaxants [neuromuscular blocking agents]Other neuromuscular dysfunction of bladderNeuromuscular dysfunction of bladder, unspecifiedNeuromuscular scoliosis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04911088
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04911088 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospital Ulm and is currently Recruiting. The study focuses on Neuromuscular Blockade. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.